Sangrix
SGRX
5 hedge funds and large institutions have $25.2K invested in Sangrix in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more funds holding
Funds holding: 3 → 5 (+2)
3.63% less ownership
Funds ownership: 3.9% → 0.27% (-3.6%)
59% less capital inflows, than outflows
Capital inflows: $25.3K | Capital outflows: $62.1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.5K |
| 2 |
Two Sigma Securities
New York
|
+$8.19K |
| 3 |
StoneX Group
New York
|
+$3.51K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$41K |
| 2 |
Victory Financial Group
Austin,
Texas
|
-$21.1K |
| 3 |
Citigroup
New York
|
-$29 |
SGRX Hedge Fund Activity: Q2 2025 in Review
5 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Sangrix (SGRX) for Q2 2025, worth a combined $25.2K — down 60% from $63K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SGRX positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $10.5K. The largest seller was Virtu Financial, exiting entirely with an estimated $41K sold.
- 5 institutional investors held Sangrix (SGRX) as of Q2 2025, up from 3 in Q1 2025.
- Funds reported $25.2K of Sangrix stock for Q2 2025, down 60% quarter-over-quarter.
- 4 funds opened new Sangrix positions in Q2 2025 and 2 closed out, a net change of +2 holders.
- The largest Sangrix buyer in Q2 2025 was UBS Group, an estimated $10.5K added.
- The largest Sangrix seller in Q2 2025 was Virtu Financial, an estimated $41K sold.
Based on aggregated 13F filings for Q2 2025.